49 www.iakardiologie.cz KAZUISTIKA / CASE REPORT The role of intracoronary thrombolysisin thrombus-laden coronary artery: a case report / Interv Akut Kardiol. 2024;23(1):43-49 / INTERVENČNÍ A AKUTNÍ KARDIOLOGIE REFERENCES 1. Jolly SS, Cairns JA, Yusuf S, et al; TOTAL Investigators. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015 Apr 9;372(15):1389-98. doi: 10.1056/NEJMoa1415098. Epub 2015 Mar 16. PMID: 25853743; PMCID: PMC4995102. 2. Ibanez B, James S, Agewall S, et al; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST- -segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST- -segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393. PMID: 28886621. 3. Sezer M, Cimen A, Aslanger E, et al. Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function. J Am Coll Cardiol. 2009 Sep 15;54(12):1065-71. doi: 10.1016/j.jacc.2009.04.083. PMID: 19744615. 4. Kumar V, Sharma AK, Kumar T, et al. Large intracoronary thrombus and its management during primary PCI. Indian Heart J. 2020 Nov-Dec;72(6):508-516. doi: 10.1016/j. ihj.2020.11.009. Epub 2020 Nov 19. PMID: 33357638; PMCID: PMC7772595. 5. Braunwald E, Zipes DP, Libby P, et al. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, Eleventh Edition. 11th ed. Philadelphia: Elsevier Inc.; 2019. 1944 p. 6. Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010 May 25;55(21):2383-9. doi: 10.1016/j. jacc.2009.12.054. PMID: 20488311. 7. Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007 Aug 14;50(7):573-83. doi: 10.1016/j.jacc.2007.04.059. Epub 2007 Jul 30. PMID: 17692740. 8. Kushner FG, Hand M, Smith SC Jr, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused Updates: ACC/ AHA Guidelines for the Management of Patients With ST- -Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 Dec 1;120(22):2271-306. doi: 10.1161/CIRCULATIONAHA.109.192663. Epub 2009 Nov 18. Erratum in: Circulation. 2010 Mar 30;121(12):e257. Dosage error in article text. PMID: 19923169. 9. Napodano M, Dariol G, Al Mamary AH, et al. Thrombus burden and myocardial damage during primary percutaneous coronary intervention. Am J Cardiol. 2014 May 1;113(9):144956. doi: 10.1016/j.amjcard.2014.01.423. Epub 2014 Feb 12. PMID: 24630783. 10. Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc Interv. 2010 Jul;3(7):695-704. doi: 10.1016/j.jcin.2010.05.004. PMID: 20650430. 11. Rezkalla SH, Stankowski RV, Hanna J, et al. Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC Cardiovasc Interv. 2017 Feb 13;10(3):215-223. doi: 10.1016/j.jcin.2016.11.059. Erratum in: JACC Cardiovasc Interv. 2017 Jun 26;10(12):1282. PMID: 28183461. 12. Gibson CM, de Lemos JA, Murphy SA, et al; TIMI Study Group. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001 May 29;103(21):2550-4. doi: 10.1161/01.cir.103.21.2550. PMID: 11382722. 13. Topaz O, Topaz A, Owen K. Thrombus grading for coronary interventions: the role of contemporary classifications. Interv Cardiol. 2011 Dec;3(6):705-12. Available from: http://www.futuremedicine.com/doi/abs/10.2217/ica.11.76. 14. De Luca G, Savonitto S, van't Hof AW, et al. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future. Drugs. 2015 Jul;75(11):1229-53. doi: 10.1007/s40265015-0425-7. PMID: 26177890. 15. Winchester DE, Wen X, Brearley WD, et al. Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. J Am Coll Cardiol. 2011 Mar 8;57(10):1190-9. doi: 10.1016/j.jacc.2010.10.030. PMID: 21371635. 16. Montalescot G, Zeymer U, Silvain J, et al; ATOLL Investigators. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet. 2011 Aug 20;378(9792):693703. doi: 10.1016/S0140-6736(11)60876-3. PMID: 21856483. 17. Silvain J, Beygui F, Barthélémy O, et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2012 Feb 3;344:e553. doi: 10.1136/bmj.e553. PMID: 22306479; PMCID: PMC3271999. 18. Capodanno D, Gargiulo G, Capranzano P, et al. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):253-62. doi: 10.1177/2048872615572599. Epub 2015 Mar 6. PMID: 25746943. 19. Alak A, Lugomirski P, Aleksova N, et al. A Meta-Analysis of Randomized Controlled Trials of Conventional Stenting Versus Direct Stenting in Patients With Acute Myocardial Infarction. The Journal of Invasive Cardiology. 2015 Sep;27(9):405409. PMID: 26121706. 20. Saad M, Stiermaier T, Fuernau G, et al. Impact of direct stenting on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction. Int J Cardiol. 2019 May 15;283:88-92. doi: 10.1016/j.ijcard.2018.11.141. Epub 2018 Dec 3. PMID: 30573280. 21. Burzotta F, De Vita M, Gu YL, et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J. 2009 Sep;30(18):2193-203. doi: 10.1093/eurheartj/ehp348. Epub 2009 Sep 2. PMID: 19726437. 22. Fröbert O, Lagerqvist B, Olivecrona GK, et al; TASTE Trial. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013 Oct 24;369(17):1587-97. doi: 10.1056/NEJMoa1308789. Epub 2013 Aug 31. Erratum in: N Engl J Med. 2014 Aug 21;371(8):786. PMID: 23991656. 23. Lagerqvist B, Fröbert O, Olivecrona GK, et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med. 2014 Sep 18;371(12):1111-20. doi: 10.1056/ NEJMoa1405707. Epub 2014 Sep 1. PMID: 25176395. 24. Jolly SS, Cairns JA, Yusuf S, et al. Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. Eur Heart J. 2015 Sep 14;36(35):2364-72. Available from: https://academic.oup.com/eurheartj/article-lookup/ doi/10.1093/eurheartj/ehv296. 25. Jolly SS, Cairns JA, Yusuf S, et al; TOTAL Investigators. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet. 2016 Jan 9;387(10014):127-35. doi: 10.1016/ S0140-6736(15)00448-1. Epub 2015 Oct 22. PMID: 26474811; PMCID: PMC5007127. 26. Jolly SS, James S, Džavík V, et al. Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration. Circulation. 2017 Jan 10;135(2):143-152. doi: 10.1161/CIRCULATIONAHA.116.025371. Epub 2016 Dec 9. PMID: 27941066. 27. Ali A, Cox D, Dib N, et al; AIMI Investigators. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol. 2006 Jul 18;48(2):244-52. doi: 10.1016/j.jacc.2006.03.044. Epub 2006 Jun 23. PMID: 16843170. 28. Migliorini A, Stabile A, Rodriguez AE, et al; JETSTENT Trial Investigators. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol. 2010 Oct 12;56(16):1298-306. doi: 10.1016/j. jacc.2010.06.011. Epub 2010 Aug 5. PMID: 20691553. 29. Carrabba N, Parodi G, Maehara A, et al. Rheolityc thrombectomy in acute myocardial infarction: Effect on microvascular obstruction, infarct size, and left ventricular remodeling. Catheter Cardiovasc Interv. 2016 Jan 1;87(1):E1-8. doi: 10.1002/ ccd.25961. Epub 2015 Jun 24. PMID: 26108162. 30. Vergara R, Valenti R, Migliorini A, et al. Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock. J Invasive Cardiol. 2016 Dec;28(12):E193-E197. Epub 2016 May 15. PMID: 27187985. 31. Goudreau E, DiSciascio G, Vetrovec GW,et al. Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complications. Am J Cardiol. 1992 Jan 1;69(1):57-62. doi: 10.1016/0002-9149(92)90676p. PMID: 1729868. 32. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST- -elevation myocardial infarction: quantitative review of randomised trials. Lancet. 2006 Feb 18;367(9510):579-88. doi: 10.1016/S0140-6736(06)68148-8. Erratum in: Lancet. 2006 May 20;367(9523):1656. PMID: 16488801. 33. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST- -segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet (London, England). 2006 Feb 18;367(9510):569-78. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673606681476. 34. Sezer M, Oflaz H, Gören T, et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med. 2007 May 3;356(18):1823-34. doi: 10.1056/NEJMoa054374. PMID: 17476008. 35. Kelly RV, Crouch E, Krumnacher H, et al. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase. Catheter Cardiovasc Interv. 2005 Nov;66(3):327-32. doi: 10.1002/ccd.20521. PMID: 16208711. 36. Boscarelli D, Vaquerizo B, Miranda-Guardiola F, et al. Intracoronary thrombolysis in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration. Eur Heart J Acute Cardiovasc Care. 2014 Sep;3(3):229-36. doi: 10.1177/2048872614527008. Epub 2014 Mar 17. PMID: 24637066. 37. Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G, White K, Goldberg RJ. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003 Oct;24(20):1815-23. doi: 10.1016/s0195-668x(03)00485-8. PMID: 14563340. 38. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/ EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. 39. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985 Apr 4;312(14):9326. doi: 10.1056/NEJM198504043121437. PMID: 4038784.
RkJQdWJsaXNoZXIy NDA4Mjc=